Top Medical Searches

BioAlliance Pharma: Presentation of Livatag Survival Results at the International Liver Cancer Congress in Hong Kong

PARIS–(BUSINESS WIRE)–Sep 5, 2011 – Regulatory News:BioAlliance Pharma SA (Paris:BIO), a company dedicated to specialtyand orphan oncology products, today announces oral communication ofthe Phase II clinical trial results of its orphan…


 Read more…

Be Sociable, Share!
September 7th, 2011 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us